Abstract
Behçet’s disease (BD) is a chronic, relapsing, systemic vasculitis with unknown etiology. During the progression of the disease, gastrointestinal involvement can be observed. The aim of this study was to find out the predictive value of the sucrose permeability test in detecting gastrointestinal mucosal damage in BD. Twenty-six male Behçet’s patients and 21 age- and sex-matched controls were enrolled in the study. Seventeen patients had active disease, while nine did not. Active disease was defined as having elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels or at least two of the diagnostic criteria in the previous month. Patients and controls were investigated with the upper gastrointestinal permeability test. Of all the patients, 25 were investigated endoscopically. The urine sucrose levels were significantly higher in patients than in the control group (P=0.0001) and in patients with active disease than those with inactive disease (P<0.0001), while urine sucrose of patients with inactive disease and the control group did not differ. The endoscopic findings were not specific to BD. Active and inactive BD had similar endoscopic findings. Increased upper gastrointestinal permeability was established in patients with BD. This increased permeability was not related to a specific gastrointestinal BD lesion. Further studies with larger series must be performed in order to determine the value of the sucrose permeability test in detecting mucosal involvement in BD.
Similar content being viewed by others
References
Abdullah AN, Keczkes K (1989) Behçet’s syndrome with gastro-intestinal tract involvement mimicking carcinoma of the caecum—a case report. Clin Exp Dermatol 14:459–461
Feigenbaum A (1956) Description of Behçet’s syndrome in the Hippocratic third book of endemic diseases. Br J Ophthalmol 40:355
Behçet H (1937) Über rezidivierende Aphthose, durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatologische Wochenschrift 105:1152
Mutlu S, Scully C (1994) The person behind the eponym: Hulusi Behçet (1889–1948). J Oral Pathol Med 23:289
Yurdakul S, Tüzüner N, Yurdakul İ, Hamuryudan V, Yazıcı H (1996) Gastrointestinal involvement in Behçet’s syndrome: a controlled study. Ann Rheum Dis 55:208–210
Anti M, Marra G, Rapaccini GL, Barone C, Manna R, Bochicchio GB, Fedeli G J (1986) Esophageal involvement in Behçet’s syndrome. J Clin Gastroenterol 8:514–519
Powderly WG, Lombard MG, Murray FE, O’Connell D, Counihan TB, Lennon JR (1987) Oesophageal ulceration in Behçet’s disease presenting with haemorrhage. Ir J Med Sci 156:193–194
Griffin JW Jr, Harrison HB, Tedesco FJ, Mills LR (1982) Behçet’s disease with multiple sites of gastrointestinal involvement. 4th South Med J 75:1405–1408
Hamuryudan V, Yurdakul S, Yazıcı H (1997) Behçet’s syndrome. Rheumatol Eur 26:31–33
De Keyser F, Elewaut D, De Vos M, De Viam K, Cuvelier C, Mielants H (1998) Bowel inflammation and the spondylarthropathies. Rheum Dis Clin North Am 24:785–813
Bjarnason I, MacPherson A, Hollander D (1995) Intestinal permeability: an overview. Gastroenterology 108:1566–1581
Meddings JB, Sutherland LR, Byles NI, Wallace JL (1993) Sucrose: a novel permeability marker for gastroduodenal disease. Gastroenterology 104:1619–1626
Sutherland LR, Verhoef M, Wallace JL, Rosendal GV, Crutcher R, Meddings JB (1994) A simple, non-invasive marker of gastric damage: sucrose permeability. Lancet 343:998–1000
Simon DJ, Mike S, Peter WRG (2001) Intestinal permeability tests in coeliac disease. Clin Lab 47:143–150
Smecuol E, Bai JC, Sugai E, Vazquez H, Niveloni S, Pedreira S, Maurino E, Meddings J (2001) Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs. Gut 49:650–655
Erlacher L, Wyatt J, Pflugbeil S, Koller M, Ullrich R, Vogelsang H, Smolen JS, Graninger W (1998) Sucrose permeability as a marker for NSAID-induced gastroduodenal injury. Clin Exp Rheumatol 16:69–71
International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
Aydıntuğ O, Tokgöz G, Özoran K, Düzgün N, Gürler A, Tutak H (1995) Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behçet’s disease. Rheumatol Int 15:75–78
Pronai L, Ichıkawa Y, Nakazawa H, Arımonı S (1991) Enhanced superoxide generation and the decreased superoxide scavenging activity of peripheral blood leukocytes in Behçet’s disease—effects of colchicine. Clin Exp Rheumatol 9:227–233
Holmes EW (1997) Coupled enzymatic assay for the determination of sucrose. Anal Biochem 244:103–109
O’Duffy JD (1978) Summary of the International Symposium on Behçet’s Disease. J Rheumatol 5:229–233
Yurdakul S (1997) Behçet sendromunun epidemiyolojisi. Aktüel Tıp Dergisi 2:66–67
Bradbury AW, Milne AA, Murie JA (1994) Surgical aspects of Behçet’s disease. Br J Surg 81:1712–1721
Shimuzu T, Ehrlich GE, Inaka G, Hayashi K (1979) Behçet disease (Behçet syndrome). Semin Arthritis Rheum 8:223–260
Baker RD, Baker SS, La Rosa K (1995) Polarized caco-2 cells: effect of reactive oxygen metabolites on enterocyte barrier function. Dig Dis Sci 40:510–518
Deitch EA, Morrison J, Berg R, Specian RD (1990) Effect of hemorrhagic shock on bacterial translocation, intestinal morphology and intestinal permeability in conventional and antibiotic contaminated rats. Crit Care Med 18:529–536
Tepperman BL, Brown JF, Korolkiewicz R, Whittle BJ (1994) Nitric oxide synthase activity. Viability and cyclic GMP levels in rat colonic epithelial cells: effect of endotoxin challenge. J Pharmacol Exp Ther 271:1477–1482
Adams RB, Planchon SM, Roche JK (1993) IFN-alpha modulation of epithelial barrier function: time course, reversibility and site of cytokine binding. J Immunol 150:2356–2363
Kızıltaş S, Imeryüz N, Gürcan T, Sıva A, Saip S, Dumanbar A, Kalaycı C, Ulusoy NB (1998) Corticosteroid therapy augments gastroduodenal permeability to sucrose. Am J Gastroenterol 93:2420–2425
Bjarnason I (1997) The intestinal permeability barrier—what is measured, what does it mean? Falk Symposium 100:17–18
Fresko I, Hamuryudan V, Demir M, Hızlı N, Sayman H, Melikoğlu M, Tunç R, Yurdakul S, Yazici H (2001) Intestinal permeability in Behçet’s syndrome. Ann Rheum Dis 60:65–66
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Koc, B., Aymelek, S., Sonmez, A. et al. Increased sucrose permeability in Behçet’s disease. Rheumatol Int 24, 347–350 (2004). https://doi.org/10.1007/s00296-003-0375-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-003-0375-3